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The DNA-dependent protein kinase (DNA-PK) is a
nuclear serine/threonine protein kinase composed of a
large catalytic subunit (DNA-PKcs) and a heterodimeric
DNA-targeting subunit Ku. DNA-PK is a major compo-
nent of the nonhomologous end-joining pathway of DNA
double-strand breaks repair. Although DNA-PK has been
biochemically characterized in vitro, relatively little is
known about its functions in the context of DNA repair
and how its kinase activity is precisely regulated in vivo.
Here, we report that cellular depletion of the individual
catalytic subunits of protein kinase CK2 by RNA
interference leads to signiﬁcant cell death in M059K
human glioblastoma cells expressing DNA-PKcs, but not
in their isogenic counterpart, that is M059J cells, devoid
of DNA-PKcs. The lack of CK2 results in enhanced
DNA-PKcs activity and strongly inhibits DNA damage-
induced autophosphorylation of DNA-PKcs at S2056 as
well as repair of DNA double-strand breaks. By the
application of the in situ proximity ligation assay, we
show that CK2 interacts with DNA-PKcs in normal
growing cells and that the association increases upon
DNA damage. These results indicate that CK2 has an
important role in the modulation of DNA-PKcs activity
and its phosphorylation status providing important
insights into the mechanisms by which DNA-PKcs is
regulated in vivo.
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Introduction
The presence of functional DNA-damage surveillance
and repair pathways is fundamental for maintaining
genomic integrity in normal cells. A wide variety of
DNA lesions leads to activation of various cell-cycle
checkpoints controlled by the PI3K-related kinases,
which allow repair of DNA damage before proceeding
further with cell proliferation (Harrison and Haber,
2006). Double-strand DNA breaks (DSBs) are considered
the biggest threat to genomic stability because, if
unrepaired or incorrectly repaired, they can lead to cell
death. Two major repair pathways have been reported
to be activated in response to DSBs: nonhomologous
end-joining (NHEJ) and homologous recombination
(Helleday et al., 2007). DNA-dependent protein kinase
(DNA-PK) is a serine/threonine kinase composed of a
catalytic subunit (DNA-PKcs) and a heterodimeric
complex of Ku70 and Ku86, which binds to the two
DNA ends in a ring conformation. This event subse-
quently activates DNA-PKcs, which promotes the
ligation of DNA ends in the presence of other
components of the NHEJ-repair machinery (Mahaney
et al., 2009). Modulation of DNA-PK activity is not
exclusively regulated by the coordinated assembly of Ku
and DNA-PKcs on DNA ends. In this respect, it has
been reported that DNA-PKcs can undergo autopho-
sphorylation (Chan et al., 2002; Douglas et al., 2002,
2007; Chen et al., 2005). To date, it is not clear which is
the exact role of this event, although some studies have
reported that autophosphorylation of puriﬁed DNA-
PKcs results in disruption of the DNA-PK complex
in vitro and loss of kinase activity in vivo (Chan and
Lees-Miller, 1996; Merkle et al., 2002; Ding et al., 2003;
Block et al., 2004; Douglas et al., 2007). This leaves
open the possibility that dissociation of the DNA-PK
complex from DNA might be necessary for facilitating
subsequent repair steps by allowing the assembly of
damage-responsive proteins to the site of DNA damage
or activating them. A total of 16 in vitro phosphoryla-
tion sites in DNA-PKcs have been identiﬁed by mass
spectrometry of which four were found phosphorylated
also in vivo in okadaic acid-treated human cells (Chan
et al., 2002). These ﬁndings represent a very important
advance in the understanding of DSB repair mechan-
isms and conﬁrm that DNA-PK implication in NHEJ
may require coordinated phosphorylation at multiple
sites (Weterings and Chen, 2007).
Protein kinase CK2 is a serine/threonine kinase highly
conserved in eukaryotic organisms so far investigated
and composed of two catalytic a and/or a0-subunits and
two regulatory b-subunits. CK2 appears distributed in
tetrameric complexes inside the cells but signiﬁcant
evidence indicates that the individual subunits do not
exist exclusively within these complexes but also as free
proteins (Litchﬁeld, 2003; Bibby and Litchﬁeld, 2005).
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CK2 is involved in cell-cycle progression and in the
regulation of intracellular signaling pathways associated
with various diseases, particularly cancer (Guerra and
Issinger, 2008; Trembley et al., 2009). Current data
suggest that CK2 is also involved in DNA sensing and
repair. One of the most compelling evidence was
reported by (Loizou et al. (2004), demonstrating that
CK2 has a direct role in the DNA repair by
phosphorylating XRCC1, thereby enabling the assembly
and activity of DNA single-strand break repair at sites
of chromosome breakage. The CK2-catalyzed phos-
phorylation of HP1-b, a chromatin factor bound to
histone H3, was found to occur in cells exposed to DNA
damage and this event was accompanied by HP1-b-
mobilization and subsequent alteration in chromatin
structure (Ayoub et al., 2008). Although mounting
evidence indicates that CK2 is implicated in the earliest
cellular response to DNA breakage, the relationship
between CK2 and components of the DNA damage
response is yet to be thoroughly explored.
In this study, by employing two human glioblastoma
cell lines, M059J and M059K, which lack and express
normal levels of DNA-PKcs, respectively, we report
evidence that downregulation of the individual CK2
catalytic subunits leads to marked cell death in cells
expressing DNA-PKcs. Furthermore, we show that
knockdown of CK2 results in decreased DNA-PKcs
autophosphorylation and persistent DNA damage follow-
ing induction of DSBs in cells. These ﬁndings suggest
that CK2 contributes to the regulation of DNA-PK in
eukaryotic cells and provide important evidence of a
prominent role of CK2 in the DNA damage response.
Results
Downregulation of protein kinase CK2 induces cell death
in glioblastoma cells expressing DNA-PKcs
We investigated the response of two human glioblasto-
ma cell lines M059K and M059J to downregulation
of the individual CK2 subunits in the presence or
absence of DNA damage induced by incubation of cells
with the radiomimetic drug neocarzinostatin (NCS;
Povirk, 1996) for 24 h. As shown in Figure 1a, transfec-
tion of cells with small interfering RNAs (siRNAs)
against the individual CK2 subunits led to a marked
reduction of the CK2 protein levels in both cell
lines. Additionally, the sole depletion of CK2a resulted
in the downregulation of CK2b, an effect that has been
previously reported (Canton et al., 2001), whereas
downregulation of CK2b negatively affected the expres-
sion of CK2a0. Reduction of CK2 protein levels caused
morphological changes in M059K cells indicative of
cell death (Figure 1b). A similar effect was observed
when cells lacking the individual CK2 subunits were
incubated with 0.5 mg/ml NCS. In the case of M059J
cells, a slight morphological change was observed
only in cells transfected with siRNA-CK2b in compar-
ison to control cells. To ensure that the indicated
morphological changes reﬂected active cell killing, ﬂow
cytometry analysis was performed for measuring cell
death (SYTOX green-positive cells) under treatment
conditions indicated in Figure 1b. In M059K cells,
reduction of CK2a and a0, respectively, led to up to
33% cell killing and this percentage was slightly higher
following incubation with NCS. CK2b downregulation
resulted in a minor but still detectable effect attributable
to the lower CK2a0 expression levels. NCS alone led to
B15% cell death in comparison to control cells. In the
case of M059J cells, downregulation of the individual
CK2 subunits, with the exception of the CK2b-siRNA
treatment, did not lead to a consistent increase in cell
death with respect to control cells. The sole NCS treat-
ment causedB33% cell death and this percentage slightly
increased in the case of cells additionally depleted of
CK2a (Figure 1c). The M059K cell line was employed
for the subsequent experiments as downregulation of the
individual CK2 catalytic subunits was most effective in
inducing cell death in cells expressing DNA-PKcs (see
also Supplementary Figure S1). Next, it was investigated
whether knockdown of the CK2 catalytic subunits would
lead to an apoptotic type of cell death in the presence
and absence of NCS, respectively, by performing a
western blot analysis of the caspase-3/caspase-7 substrate
poly(ADP-ribose) polymerase (PARP) (Figure 2a).
A slight cleavage of full-length PARP was observed in
cells treated with NCS (lane 4), whereas the additional
treatment with transfection reagent (lane 5) or with
siRNA against the individual CK2 catalytic subunits
(lanes 6 and 7) did not lead to a further increase in
PARP cleavage. Results in Figure 2a were followed by a
quantitative determination of the percentage of
dead cells following the treatments indicated above
and in the presence and absence of the broad-range
caspase inhibitor zVAD-fmk or cystein cathepsin
inhibitor zFA-fmk, respectively. Results reported in
Figure 2b showed that the toxicity induced by cellular
depletion of CK2a or -a0 was not reduced when cells
were treated with zVAD-fmk or zFA-fmk (see also
Supplementary Figures S2a and b). Similar results were
obtained when cells were additionally incubated with
NCS. These results suggest that although a small
proportion of cells undergoes apoptosis (Figure 2a),
both caspases and lysosomal proteases are not involved
in the mechanism of cell death. Autophagy induction
has been reported in malignant glioma cells exposed to
ionizing radiation (Yao et al., 2003). To determine
whether the aforementioned treatments induced
autophagic cell death in M059K cells, cells were
incubated with monodansylcadaverine (MDC), a spe-
ciﬁc ﬂuorescent autophagosome marker (Biederbick
et al., 1995), and MDC-positive cells were quantiﬁed
by ﬂow cytometry. Results in Figure 2c indicate that the
proportion of MDC-positive cells increased approxi-
mately from 8% (control cells) to 15% (CK2a and
-a0 siRNA treatment, respectively) in M059K cells.
When cells were additionally incubated with NCS, the
percentage of cells undergoing autophagy varied
approximately from 14% (NCS-treated cells) to
20% (NCS treatment and downregulation of the
individual CK2 subunits, also see Supplementary
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Figure S2). Overall, these results suggest that
the cytotoxicity is predominantly due to induction
of an autophagic type of cell death and that down-
regulation of the individual CK2 catalytic subunits
contributes to enhance the toxicity of NCS in M059K
cells.
Figure 1 Downregulation of CK2 leads to cell death in the human glioblastoma cell line M059K. (a) M059K and M059J cells
were treated with transfection reagent only (control) or with siRNAs against the individual CK2 subunits for 72 h. Where indicated,
0.5 mg/ml NCS were added during the last 24 h of incubation with siRNA. Whole lysates were analyzed by western blot with antibodies
against the indicated proteins. Detection of b-actin protein was used as a loading control. Band quantitation was obtained by analysis
with ImageJ software. Values below each band were calculated assigning the value 1.0 to results from the control experiment.
(b) Phase-contrast microscopy pictures of cells treated as described above showing morphological changes indicating various degrees of
toxicity induced by the aforementioned treatments. Original magniﬁcation:  400. (c) Quantiﬁcation of cell death was performed by
ﬂow cytometry analysis of SYTOX green-positive cells. Bars indicate the average from three independent experiments þ /s.d.
*Po0.05 denotes statistically signiﬁcant differences with respect to control. No statistical signiﬁcant differences were found between
cells depleted of CK2 in the absence or presence of NCS. In all cases, experiments were repeated at least three times and data from one
representative experiment are shown. TR, transfection reagent.
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Downregulation of the individual CK2 catalytic subunits
affects the activity and autophosphorylation status of
DNA-PK
As the downregulation of CK2 alone or in combination
with NCS contributed to enhance the cytotoxicity of
M059K cells, it was investigated whether these effects
were due to CK2-mediated modulation of DNA-PK
activity and/or expression. Cells were treated as
indicated in Figure 3a and Supplementary Figure S3,
and the kinase activity of DNA-PK was analyzed by
employing a speciﬁc peptide substrate. Knockdown of
CK2a or -a0 led to a marked increase in DNA-PK
activity (B40%) in comparison with the control
experiment. As expected, the sole treatment with NCS
resulted in 40% increase in DNA-PK activity with
respect to control cells. The activity of DNA-PK further
increased B20%, with respect to NCS-treated cells, in
cells additionally lacking CK2a or -a0. Western blot
analysis of the expression levels of DNA-PKcs and the
Ku subunits excluded that the observed upregulation of
DNA-PK activity was due to altered protein levels of
the DNA-PK complex (Figure 3b). In vitro experiments
performed, employing various combinations of the
indicated recombinant proteins in an increasing molar
ratio, showed a direct CK2-mediated negative modula-
tion of DNA-PK kinase activity with respect to control
experiments performed with native DNA-PKcs
(Figure 3c). Moreover, in vitro phosphorylation experi-
ments performed in the presence of DNA-PKcs as a
potential substrate target for CK2, excluded that the
observed downregulation of DNA-PK activity was due
to CK2-mediated phosphorylation of DNA-PK (data
not shown). Nevertheless, both KU70 and KU86
appeared to be substrates of CK2a in vitro (Supplemen-
tary Figure S7). The ataxia telangiectasia-mutated
(ATM) gene product has been shown to phosphorylate
and positively regulate the kinase activity of DNA-PK
(Chen et al., 2007). In order to determine whether ATM
kinase contributed to enhance the activity of DNA-PK
in knockdown CK2a and -a0 cells, respectively, M059K
cells were left untreated or incubated with the speciﬁc
ATM kinase inhibitor, KU55933. Results shown in
Figures 3d and e, excluded that the enhanced DNA-PK
activity observed in cells with lowered CK2a or -a0
expression levels was mediated by ATM kinase
(Figure 3d), although control experiments performed
by measuring the level of phosphorylation of down-
stream targets of ATM showed that the incubation of
cells with 10 mM KU55933 for 4 h was sufﬁcient to
induce a marked inhibition of ATM in vivo (Figure 3e).
Recent in vivo studies indicated that incubation of
cells with DNA-damaging agents leads to autopho-
sphorylation of DNA-PKcs at S2056. This event is
accompanied by decreased DNA-PK kinase activity that
is essential for the repair of DNA double-strand breaks
(Chan and Lees-Miller, 1996; Merkle et al., 2002).
To understand the mechanism by which the activity of
DNA-PK is regulated by the individual CK2 catalytic
subunits, whole extracts from M059K cells treated as
indicated in Figure 4a (see also Supplementary Figure
S4) were analyzed by western blot. Treatment for 1 h
with 0.5 mg/ml NCS alone or with NCS and transfection
reagent led to marked autophosphorylation of DNA-
PKcs at S2056 (lanes 4 and 5) with respect to the control
experiment (lane 1). The sole depletion of CK2a or
-a0 did not cause phosphorylation of DNA-PKcs (lanes
2 and 3). Surprisingly, incubation of CK2a- or
Figure 2 CK2 downregulation leads to an autophagic type of cell
death. (a) M059K cells incubated with transfection reagent only
(control) or transfected with siRNA against the individual CK2
catalytic subunits for 72 h and incubated in the presence or absence
of 0.5 mg/ml NCS for 24 h, as indicated in the ﬁgure, were subjected
to western blot analysis of PARP cleavage. Full-length PARP
(116 kDa) and its cleavage product (85 kDa) are indicated. (b) Cells
treated as described above were additionally incubated with 5 mM
zVAD-fmk or 85mM zFA-fmk in combination with 0.5mg/ml NCS
for 24 h. Bars indicate average from three independent experiments
þ /s.d. (c) M059K cells treated as described above were stained
with 50mM MDC as indication of autophagy. Quantiﬁcation of
MDC-positive cells was performed by FACS analysis. Average of
three independent experiments þ /s.d. is shown. *Po0.05
compared with control experiment; **Po0.01 compared with
NCS-treated cells. TR, transfection reagent.
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-a0-knockdown cells with NCS caused a marked decrease
in DNA-PKcs autophosphorylation (lanes 6 and 7) while
its expression levels remained unchanged. In order to see
whether CK2 kinase activity had a role in the modula-
tion of DNA-PKcs autophosphorylation, cells were
incubated with 40mM resoruﬁn, a highly speciﬁc CK2
Figure 3 Positive modulation of DNA-PKcs activity following CK2 downregulation. (a) M059K cells were treated as described in
Figure 1a. Whole-cell lysates were employed for determination of endogenous DNA-PKcs activity. DNA-PKcs activity is expressed as
percentage of control. The activity of DNA-PKcs contained in extracts from M059J treated with 0.5mg/ml NCS for 24 h was also
included in the assay as a control. Bars indicate mean þ /s.d. of three independent experiments. *Po0.01 compared with control
experiment; **Po0.01 compared with NCS-treated cells. (b) Whole lysate from cells treated as indicated above was subjected to
western blot analysis of various proteins as indicated in the ﬁgure. (c) Bar graph showing the inﬂuence of increasing amount of various
types of CK2 on DNA-PKcs activity measured in phosphorylation assays in the presence of a peptide substrate speciﬁc for DNA-PKcs
(Achari and Lees-Miller, 2000). Kinase activity is expressed as percentage of control. The ratio between CK2 and DNA-PKcs is
expressed in picomol. (d) Kinase activity of endogenous DNA-PKcs in whole extract from cells incubated with transfection reagent or
transfected with siRNAs against the individual CK2 catalytic subunits. Where indicated, cells were incubated with 10 mM KU55933
(ATM inhibitor) for 4 h. Bars indicate means þ /s.d. of two independent experiments. (e) Western blot analysis of crude extracts
from M059K cells left untreated or incubated with KU55933 for verifying the effectiveness of inhibition of endogenous ATM.
The phosphorylation and protein levels of downstream substrate targets of ATM are shown in the ﬁgure. TR, transfection reagent.
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kinase inhibitor (Sandholt et al., 2009), for 24 h in the
presence or absence of 0.5 mg/ml NCS for 1 h. Incuba-
tion of cells with resoruﬁn inhibited B40% of endo-
genous CK2 activity (Figure 4b). Moreover, the
presence of resoruﬁn did not affect the autophosphor-
ylation of DNA-PK induced by NCS (Figure 4c; lanes 3
and 4). Overall, these results suggest that the mechanism
by which CK2 modulates the activity and the autopho-
sphorylation of DNA-PKcs is not caused by CK2-
mediated phosphorylation or changes in the expression
levels of DNA-PKcs.
Downregulation of CK2 inhibits DNA-PK-dependent
DNA double-strand break repair
Next it was investigated whether CK2-knockdown-
mediated inhibition of DNA-PKcs autophosphorylation
impairs DNA DSB repair. The analysis of cells
incubated with 0.5 mg/ml NCS for the indicated times
and subsequently stained with anti-phospho-histone
H2AX(S139) antibody for visualizing nuclear foci of
DNA damage (Kuo and Yang, 2008) revealed a
signiﬁcant enhancement in residual DNA damage in
CK2a- or -a0-knockdown cells with respect to cells
treated with only NCS (Figure 5a). Quantiﬁcation of the
number of p-H2AX-positive cells revealed that although
40% of the total number of cells was still presenting
DNA damage 24 h after the initial incubation with NCS,
B80% of cells lacking the individual CK2 catalytic
subunits were still p-H2AX positive after 24 h
(Figure 5b). Western blot analysis of whole extracts
from cells treated as described above further conﬁrmed
the results (Figure 5c and Supplementary Figure S5).
To further analyze the ability to repair DNA damage in
cells lacking CK2a or -a0, a previously established
plasmid-based (that is, pEGFP-N1) end-joining assay
was utilized (Wang et al., 2006). Quantiﬁcation of green
ﬂuorescent protein (GFP)-positive cells by ﬂuorescence-
activated cell sorting analysis showed that there were
B40% less GFP-positive cells in CK2-knockdown cells
in comparison with the control assay (Figure 5d).
The results of these experiments clearly support the
idea that CK2 might contribute to the autophosphor-
ylation of DNA-PKcs at S2056, which occurs in vivo
following DNA damage, by bringing DNA-PKcs
molecules in close proximity. Hence, it was investigated
whether CK2 interacts with DNA-PKcs in cells left
untreated or exposed to DNA damage by performing an
in situ proximity ligation assay that enables the detection
and quantiﬁcation of protein–protein interactions
in native cells (So¨derberg et al., 2006). Results shown
in Figure 6a clearly indicated the presence of prominent
Figure 4 Lack of CK2a or -a0 leads to decreased DNA-PKcs autophosphorylation upon DNA damage. (a) M059K cells were treated
as described in Figure 1a. Whole extracts were employed for western blot analysis of the indicated proteins. Experiments were
performed three times obtaining similar results. Data from one representative experiment are shown. (b) Protein extracts from cells left
untreated, incubated with 40mM resoruﬁn for 24 h, 0.5mg/ml NCS for 1 h or a combination of resoruﬁn and NCS were analyzed for
CK2 kinase activity. The activity of endogenous CK2 is expressed as percentage of control. (c) Western blot analysis of whole lysate
from cells treated as described above was performed employing antibodies against the indicated proteins.
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signals in ﬁxed M059K cells, indicative of the existence
of endogenous interacting proteins, in control cells.
Interestingly, the number of signals markedly increased
in cells exposed to 0.5 mg/ml NCS for 1 h (see also
Supplementary Figure S6). The morphological
evaluation obtained by ﬂuorescence microscopy was
Figure 5 Downregulation of CK2 inhibits DNA-PKcs-dependent DNA double-strand break repair. (a) Photomicrographs of
cells treated with NCS or a combination of NCS and CK2-siRNAs analyzed at various time points as indicated in the ﬁgure. Cells
were labeled with anti-phospho-histone H2AX antibody and with a FITC-conjugated secondary antibody. Cellular DNA was
counterstained with DAPI (blue ﬂuorescence). Intense green ﬂuorescence indicates large numbers of foci of DNA double-strand
breaks. (b) Quantiﬁcation of the number of green ﬂuorescence-positive cells, labeled as described above, was performed by using
ImageJ software and expressed as percentage of the total number of cells in each sample. Bars indicate means þ /s.d. of four
independent experiments. *Po0.05 indicates signiﬁcant enhancement of number of green ﬂuorescence-positive cells in CK2 siRNA-
treated cells exposed to NCS compared with the corresponding control experiments. (c) Detection of DNA-PKcs autophosphorylation
and histone H2AX phosphorylation by western blot analysis of crude extracts from cells treated as described above. A representative
of two independent experiments is shown. (d) In vivo end-joining assay performed employing pEGFP-N1-plasmid DNA. End-joining
activity was calculated as the ratio between the number of GFP-positive cells following electroporation with the HindIII-digested
plasmid and the amount of GFP-positive cells after electroporation with the circular plasmid, respectively. The quantiﬁcation was
performed by assigning a value of 100% to the ratio calculated for the control experiment. Quantiﬁcation of the number of green
ﬂuorescence-positive cells was performed by FACS analysis. Bars represent mean þ /s.d. of three independent experiments. *Po0.05
denotes statistically signiﬁcant differences. TR, transfection reagent.
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accompanied by a quantitative analysis of red ﬂuor-
escent-positive cells and results shown in Figure 6b
demonstrate that the number of signals per cell
increased by a factor of 2.5 in cells treated with NCS
with respect to control experiment.
Discussion
In eukaryotic cells, the repair process of DSBs comprises
two mechanisms namely the homologous recombination
and NHEJ. NHEJ is the predominant repair pathway in
mammalian cells and can be operational in all phases of
the cell cycle. The DNA-PK complex and, in particular,
DNA-PKcs, has a key role in NHEJ by localizing
rapidly to DNA breaks and phosphorylating itself. The
role of CK2 with respect to the DNA damage response
has been analyzed in several model systems. In this
study, we aimed to investigate the possible role of CK2
as an essential regulatory component of DNA-PKcs.
The analysis of two isogenic human glioblastoma cell
lines, M059K and M059J, which express and lack DNA-
PKcs, respectively, revealed pronounced differences in
the response to cellular depletion of protein kinase CK2.
Cell death was induced in M059K but not in M059J cells
upon treatment with CK2-siRNA against the individual
catalytic subunits. Lack of signiﬁcant cell death in
M059J cells permitted to exclude a direct responsibility
of CK2, although this kinase has been shown to be
essential for viability and proliferation in many cell
systems (St-Denis and Litchﬁeld, 2009). The results
presented here provide for the ﬁrst time in vivo evidence
that CK2 is essential for modulating DNA-PK activity
in normal and DNA-damaged cells by physical interac-
tion and modulation of DNA-PKcs autophosphoryla-
tion. In the absence of DNA damage, targeting CK2a or
-a0 by siRNA strongly enhances DNA-PKcs activity.
As we did not observe CK2-mediated phosphorylation
of DNA-PKcs in vitro, this suggests that phosphoryla-
tion is not involved in the modulation of DNA-PK
activity. Furthermore chemical inhibition of CK2 with
resoruﬁn did not affect the autophosphorylation of
DNA-PKcs, excluding a role mediated by CK2 kinase
activity. However, both KU proteins were found phos-
phorylated by CK2a in vitro. Although the physio-
logical effects of these phosphorylations remain to be
elucidated, results indicate that CK2 might modulate
DNA-PK activity via the KU proteins. Data obtained
in vivo by the application of the in situ proximity liga-
tion assay and in vitro by using recombinant proteins
indicated that CK2 does interact with DNA-PKcs and
negatively modulates its kinase activity. Cells lacking
CK2 have higher DNA-PKcs activity and undergo
cell death in support of the notion of a pro-cell death
role of DNA-PK possibly via modulation of p53 as
reported previously (Wang et al., 2000; Woo et al.,
2002). Following induction of DNA damage, down-
regulation of the individual CK2 catalytic subunits led
to extensive cell death in M059K cells indicating that the
lack of CK2 sensitized cancer cells to NCS treatment.
This was accompanied by a marked decrease of DNA-
PKcs autophosphorylation at S2056 with respect to cells
treated solely with NCS. Moreover, CK2 downregula-
tion resulted in a signiﬁcant impairment of DNA DSBs
repair as indicated by the persistent phosphorylation of
histone H2AX in CK2-knockdown cells. Overall, these
results provide evidence that block of DNA repair might
be the consequence of the CK2-mediated cellular
inhibition of DNA-PKcs. Having shown that down-
regulation of the individual CK2 catalytic subunits
lowers DNA-PKcs autophosphorylation, the mechan-
ism by which this effect is achieved remains to be
elucidated. Further experiments are necessary to
Figure 6 Detection of endogenous CK2-DNA-PKcs complexes by
in situ proximity ligation assay (PLA). (a) Complexes between
endogenous CK2a0 and DNA-PKcs were visualized by staining
M059K cells left untreated (control) or incubated with 0.5mg/ml
NCS for 1 h with antibodies against CK2a0 and DNA-PKcs. Nuclei
were counterstained with Hoechst (blue). No Ab, refers to control
assay where cells were incubated with only secondary antibodies.
Each red dot represents an interaction detected by the assay
between CK2a0 and DNA-PKcs targeted by two primary
antibodies. (b) Quantiﬁcation of the number of signals per cell as
distinct ﬂuorescent red spots was performed by computer-assisted
image analysis as reported in the Materials and methods. Mean
þ /s.d. of three independent experiments is shown. *Po0.001
indicates statistically signiﬁcant differences.
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substantiate the ﬁndings reported here, yet the enhanced
physical interaction between CK2 and DNA-PKcs
observed in cells treated with NCS strongly suggests
that CK2 might be necessary to bring DNA-PKcs
molecules in close proximity, by creating a docking site
that facilitates intermolecular autophosphorylation of
DNA-PKcs. Previously, it has been suggested that
autophosphorylation at more than one site is likely to
be required for DNA-PKcs function in NHEJ in vivo
(Uematsu et al., 2007). Phosphorylation of DNA-PKcs
at S2056 as well as at T2609 has been shown to occur
in vivo in response to DNA damage (Chan et al., 2002;
Douglas et al., 2002). Compelling evidence based on
location, model systems and response to various
DNA-damaging agents indicates that these amino-acid
residues may be distinctly regulated. Although it is not
yet clear whether the phosphorylation of the aforemen-
tioned amino acids reﬂects their different roles in the
DNA-PKcs-mediated NHEJ repair, it certainly merits
to further investigate the role of CK2 with respect to
T2609 phosphorylation. Moreover, the identiﬁcation of
potential p-S2056-binding proteins in control and
in CK2-depleted cells, respectively, would certainly
contribute to unveil the DNA-PKcs-mediated molecular
mechanisms operating in the NHEJ-repair pathway.
In summary, we show that CK2 contributes to
regulate the kinase activity and autophosphorylation
of DNA-PKcs in cells. Strong evidence indicates that
CK2 interacts in vivo with DNA-PKcs in normal
growing cells and that the association increases in cells
exposed to DNA damage. The lack of CK2 in cells
treated with NCS is accompanied by marked decrease in
DNA-PKcs autophosphorylation; this suggests that
CK2 is essential for facilitating the interaction of
DNA-PKcs molecules. Downregulation of CK2 sensi-
tizes M059K cells to NCS treatment. Thus, we believe
that CK2 may be an excellent target to overcome
resistance of DNA-PKcs-proﬁcient brain tumor cells
toward radiation therapy.
Materials and methods
Cell culture
The human glioblastoma cell lines M059K and M059J were
obtained from the American Type Culture Collection (Rock-
ville, MD, USA). The cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen, Taastrup, Denmark)
supplemented with 10% fetal bovine serum and maintained at
37 1C under 5% CO2.
Transfection and cell treatments
Cells were transfected with a set of four siRNA duplexes
directed against CK2a, CK2a0 and CK2b (ON-TARGET plus
SMARTpools), respectively, using Dharmafect I (Dharmacon,
Lafayette, CO, USA) for 72 h according to the manufacturer’s
instructions. Where indicated, cells were incubated with the
radiomimetic drug NCS (a gift from Dr Hiroshi Maeda,
Kumamoto University, Japan). Dead cells were measured with
a FACSCalibur ﬂow cytometer following the SYTOX green-
based assay (Invitrogen) as previously described (Yde et al.,
2007). Endogenous CK2 activity was inhibited by incubating
M059K cells with 40 mM resoruﬁn (Sigma, Brondby, Denmark)
for 23 h before the addition of 0.5mg/ml NCS for 1 h.
Endogenous ATM was inhibited by incubating M059K cells
with 10mM KU55933 (Calbiochem, Nottingham, UK) for 4 h.
To determine the mode of cell death, M059K cells were
incubated with 0.5mg/ml NCS for 24 h in combination with
5mM z-Val-Ala-Asp-ﬂuoromethylketone (zVAD(OMe)-fmk;
Calbiochem) or 85mM z-Phe-Ala-fmk (zFA-fmk; Calbiochem)
for inhibition of caspases or cathepsins, respectively. Autop-
hagy was analyzed by ﬂow cytometry using MDC as reported
(Zhang et al., 2009). Further details are provided in
Supplementary Materials and Methods.
Western blot analysis
Whole-cell extracts and immunoblotting were as described
(Achari and Lees-Miller, 2000; Olsen and Guerra, 2008a). The
antibodies used were the following: mouse monoclonal anti-
CK2b, -CK2a and -p53 (all from Calbiochem); rabbit
polyclonal anti-CK2a0 obtained by immunizing rabbits with
a speciﬁc peptide (SQPCADNAVLSSGTAAR) of human
CK2a0; mouse monoclonal anti-b-actin (Sigma); mouse
monoclonal anti-PARP (BD Pharmingen, San Diego, CA,
USA), rabbit polyclonal anti-KU86 and anti-BID, mouse
monoclonal anti-KU70 and anti-DNA-PKcs (all from Santa
Cruz Biotechnology, Santa Cruz, CA, USA); rabbit polyclonal
anti-Chk2 (p-T68), anti-p53 (p-S15) and anti-H2AX (p-S139)
(all from Cell Signaling Technology, Beverly, MA, USA);
rabbit polyclonal anti-DNA-PKcs (p-S2056) (Abcam, Cam-
bridge, UK); and rabbit polyclonal anti-BID (p-S78) (Bethyl
Laboratories, Montgomery, TX, USA) and mouse monoclonal
anti-CHK2 (Upstate Biotechnology, Frederikssund, Denmark).
Puriﬁcation of recombinant proteins
CK2a, CK2a0, CK2a2b2 and CK2a02b2 were expressed and
puriﬁed as previously described (Nieﬁnd et al., 2000; Olsen
et al., 2006, 2008b). DNA-PK was puriﬁed from K562 cells
essentially as described (Matsumoto et al., 1997).
In vitro protein kinase assay
The activity of DNA-PK in high-salt whole extracts from
M059K and M059J cells and kinase assays employing puriﬁed
DNA-PK and recombinant CK2 were measured as described
(Achari and Lees-Miller, 2000). Further details are provided in
Supplementary Materials and Methods.
Immunoﬂuorescence and in situ proximity ligation assay
M059K cells grown on coverslips were incubated with rabbit
polyclonal anti-H2AX (p-S139) antibody (Cell Signaling Techno-
logy) followed by incubation with biotinylated swine anti-rabbit
IgG (Dako, Glostrup, Denmark) and streptavidin-conjugated
ﬂuorescein-isothiocyanate (Dako) as previously described
(Olsen and Guerra, 2008a). Cells were counterstained with
40,6-diamidino-2-phenylindole, analyzed on a DMRBE micro-
scope ( 630 magniﬁcation) equipped with a Leica DFC420C
camera (Leica, Herlev, Denmark) and processed using ImageJ
software (NIH, Bethesda, MD, USA). Cells grown on cover-
slips were analyzed for DNA-PKcs/CK2a0 interactions using a
monoclonal anti-DNA-PKcs antibody (Santa Cruz Biotechno-
logy) and a rabbit polyclonal antibody against CK2a0 according
to the manufacturer’s instructions (Olink Biosciences, Uppsala,
Sweden). The number of in situ proximity ligation signals was
counted using the freeware software Blobﬁnder (http://www.
cb.uu.se/Bamin/BlobFinder). Nuclei were visualized by Hoechst
staining. Further details are provided in SupplementaryMaterials
and Methods.
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In vivo DNA end-joining assay
The plasmid-based end-joining assay was performed as
previously described (Wang et al., 2006). pEGFP-N1 (Clon-
tech-Takara Bio Europe, Saint-Germain-en-Laye, France) was
linearized using HindIII (Fermentas, St Leon-Rot, Germany),
which cuts between the promoter and the coding region of
GFP. M059K cells were transfected with siRNA against CK2a
or CK2a0. At 48 h after transfection, cells were electroporated
(NEON Tranfection system, Invitrogen) with linear or circular
pEGFP-N1 according to the manufacturer’s instructions, and
at 24 h after electroporation, the GFP intensity was detected
by ﬂow cytometry. Further details are provided in Supple-
mentary Materials and Methods.
Statistical and densitometrical analysis
The statistical signiﬁcance of differences between the means of
two groups was evaluated by the two-tailed t-test and the level
of signiﬁcance was set as indicated in the ﬁgure legends.
Quantiﬁcation of the intensity of protein bands on western
blots was performed with the ImageJ software (NIH).
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